Literature DB >> 12174890

High concentration of beta-defensin-2 in oral squamous cell carcinoma.

Koichi Sawaki1, Nobuyoshi Mizukawa, Tomoichiro Yamaai, Tomohito Yoshimoto, Makoto Nakano, Toshio Sugahara.   

Abstract

We have previously reported the presence of human beta-defensin-2 (HBD-2), a peptide with antimicrobial and cytotoxic properties, in oral squamous cell carcinomas. The aim of the present study was to measure the concentration of HBD-2 in abnormal tissues such as oral squamous cell carcinomas. HBD-2 was extracted from tissue samples in the presence of retinoic acid and subjected to reversed-phase HPLC. The fraction representing peak 17 (P17) was obtained by elution using a linear gradient of acetonitrile. Amino acid sequencing and homology studies were subsequently performed, and the molecular weight of P17 was calculated to be 432702 daltons. This molecular weight was consistent with HBD-2. The concentration of HBD-2 in the oral squamous cell carcinoma samples was 3.85+/-1.87 microg/mg which was much higher than in normal oral epithelium (0.04+/-0.02 microg/mg).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174890

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Capacity of human beta-defensin expression in gene-transduced and cytokine-induced cells.

Authors:  Chunyi Yin; Hoa N Dang; Hai-Bo Zhang; Farzad Gazor; Daniel Kim; Ole E Sorensen; George T-J Huang
Journal:  Biochem Biophys Res Commun       Date:  2005-11-15       Impact factor: 3.575

Review 2.  Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection?

Authors:  C W Cutler; R Jotwani
Journal:  Adv Dent Res       Date:  2006-04-01

3.  NOD1, RIP2 and Caspase12 are potentially novel biomarkers for oral squamous cell carcinoma development and progression.

Authors:  Xiang Wang; Wenhui Jiang; Ning Duan; Yajie Qian; Qian Zhou; Pei Ye; Hongliu Jiang; Yang Bai; Weiyun Zhang; Wenmei Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms.

Authors:  Aprille Seidel; Ying Ye; Lesley R de Armas; Maira Soto; William Yarosh; Renee A Marcsisin; Dat Tran; Michael E Selsted; David Camerini
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

Review 5.  Role of beta-defensins in oral epithelial health and disease.

Authors:  Yoshihiro Abiko; Masto Saitoh; Michiko Nishimura; Mami Yamazaki; Daisuke Sawamura; Tohru Kaku
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

6.  Effect of human beta-defensin-3 on head and neck cancer cell migration using micro-fabricated cell islands.

Authors:  Kevin Wang; Joanne H Wang; Harihara Baskaran; Russell Wang; Rick Jurevic
Journal:  Head Neck Oncol       Date:  2012-06-28

7.  Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients.

Authors:  Beda Muehleisen; Shang Brian Jiang; Julie A Gladsjo; Monika Gerber; Tissa Hata; Richard L Gallo
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

8.  Toluene Exposure Leads to a Change in Expression Patterns of β Defensins in the Mouse Tracheal Epithelium.

Authors:  Seiko Takeda; Tomoichiro Yamaai; Yoshihiro Kaneda; Nobuyoshi Mizukawa; Seiji Iida; Hidekazu Fujimaki
Journal:  J Toxicol Pathol       Date:  2013-04-22       Impact factor: 1.628

9.  The yin and yang of human Beta-defensins in health and disease.

Authors:  Aaron Weinberg; Ge Jin; Scott Sieg; Thomas S McCormick
Journal:  Front Immunol       Date:  2012-10-08       Impact factor: 7.561

10.  Intense THz pulses down-regulate genes associated with skin cancer and psoriasis: a new therapeutic avenue?

Authors:  Lyubov V Titova; Ayesheshim K Ayesheshim; Andrey Golubov; Rocio Rodriguez-Juarez; Rafal Woycicki; Frank A Hegmann; Olga Kovalchuk
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.